Key Drivers
- Strong FCF
- Elevated leverage
- Rich multiples
AIAI Summary
Ensign has shifted from a pure roll‑up to a cash‑generative, execution‑dependent operator whose rich multiple now prices sustained occupancy and reimbursement improvement—treat the stock as a bet on management delivering mid‑80s same‑store occupancy and stable Medicare/managed‑care rates because failure to do so (given material leverage) will quickly compress valuation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •Elevated leverage
- •Rich multiples
Ensign Group delivers strong free cash flow and efficient operations but carries elevated debt and rich valuation that heighten downside risk.
Price Behavior
Key Price Behavior Insights:
- •Short‑term downtrend
- •Loss of recent support
- •Medium‑term support
ENSG is in a short‑term downtrend after rolling over from the early‑March high and closing near $200, about 5% below its last‑month SMA (~$211), signaling a corrective pullback that risks further downside unless price reclaims the $207–$211 area.
Broke below the ~$207 support band after peaking at $215.83 on 2026-03-02, indicating a corrective drop rather than capitulation
Sentiment & News
Key News Insights:
- •Expansion activity
- •Analyst buy-consensus
- •Dividend declared
Ensign Group shows growth-driven momentum—acquisitions, facility upgrades, analyst/institutional support, a new dividend and a 52-week high underpin positive sentiment.
These developments enhance revenue visibility and investor confidence, likely maintaining upward pressure on the stock in the near term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings